in the eye fundus of a healthy volunteer.|alt= During each heartbeat, blood pressure varies between a maximum (systolic) and a minimum (diastolic) pressure. The blood pressure in the circulation is principally due to the pumping action of the heart. However, blood pressure is also regulated by neural regulation from the brain (see
Hypertension and the brain), as well as osmotic regulation from the kidney. Differences in mean blood pressure drive the flow of blood around the circulation. The rate of mean blood flow depends on both blood pressure and the resistance to flow presented by the blood vessels. In the absence of
hydrostatic effects (e.g. standing), mean blood pressure decreases as the
circulating blood moves away from the heart through arteries and
capillaries due to
viscous losses of energy. Mean blood pressure drops over the whole circulation, although most of the fall occurs along the small arteries and
arterioles. Pulsatility also diminishes in the smaller elements of the arterial circulation, although some transmitted pulsatility is observed in capillaries. Gravity affects blood pressure via hydrostatic forces (e.g., during standing), and valves in veins,
breathing, and pumping from contraction of skeletal muscles also influence blood pressure, particularly in veins.
systemic vascular resistance, or
arterial stiffness (the inverse of arterial compliance). Cardiac output is the product of stroke volume and heart rate. Stroke volume is influenced by 1) the
end-diastolic volume or filling pressure of the ventricle acting via the
Frank–Starling mechanism—this is influenced by
blood volume; 2)
cardiac contractility; and 3)
afterload, the impedance to blood flow presented by the circulation. In the short-term, the greater the blood volume, the higher the cardiac output. This has been proposed as an explanation of the relationship between high dietary salt intake and increased blood pressure; however, responses to increased dietary sodium intake vary between individuals and are highly dependent on autonomic nervous system responses and the
renin–angiotensin system, changes in
plasma osmolarity may also be important. In the longer-term the relationship between volume and blood pressure is more complex. In simple terms, systemic vascular resistance is mainly determined by the caliber of small arteries and arterioles. The resistance attributable to a blood vessel depends on its radius as described by the
Hagen-Poiseuille's equation (resistance∝1/radius4). Hence, the smaller the radius, the higher the resistance. Other physical factors that affect resistance include: vessel length (the longer the vessel, the higher the resistance), blood viscosity (the higher the viscosity, the higher the resistance) and the number of vessels, particularly the smaller numerous, arterioles and capillaries. The presence of a severe arterial
stenosis increases resistance to flow, however this increase in resistance rarely increases systemic blood pressure because its contribution to total systemic resistance is small, although it may profoundly decrease downstream flow. Substances called
vasoconstrictors reduce the caliber of blood vessels, thereby increasing blood pressure.
Vasodilators (such as
nitroglycerin) increase the caliber of blood vessels, thereby decreasing arterial pressure. In the longer term a process termed remodeling also contributes to changing the caliber of small blood vessels and influencing resistance and reactivity to vasoactive agents. Reductions in capillary density, termed capillary rarefaction, may also contribute to increased resistance in some circumstances. In practice, each individual's autonomic nervous system and other systems regulating blood pressure, notably the kidney, respond to and regulate all these factors so that, although the above issues are important, they rarely act in isolation and the actual arterial pressure response of a given individual can vary widely in the short and long term.
Pulse pressure The pulse pressure is the difference between the measured systolic and diastolic pressures,
Clinical significance of pulse pressure A healthy pulse pressure is around 40 mmHg. A pulse pressure that is consistently 60 mmHg or greater is likely to be associated with disease, and a pulse pressure of 50 mmHg or more increases the risk of
cardiovascular disease as well as other complications such as eye and kidney disease. Pulse pressure is considered low if it is less than 25% of the systolic. (For example, if the systolic pressure is 120 mmHg, then the pulse pressure would be considered low if it is less than 30 mmHg, since 30 is 25% of 120.) A very low pulse pressure can be a symptom of disorders such as
congestive heart failure. This increased risk exists for both men and women and even when no other cardiovascular risk factors are present. The increased risk also exists even in cases in which diastolic pressure decreases over time while systolic remains steady. A
meta-analysis in 2000 showed that a 10 mmHg increase in pulse pressure was associated with a 20% increased risk of cardiovascular mortality, and a 13% increase in risk for all coronary end points. The study authors also noted that, while risks of cardiovascular end points do increase with higher systolic pressures, at any given systolic blood pressure the risk of major cardiovascular end points increases, rather than decreases, with lower diastolic levels. This suggests that interventions that lower diastolic pressure without also lowering systolic pressure (and thus lowering pulse pressure) could actually be counterproductive. There are no drugs currently approved to lower pulse pressure, although some antihypertensive drugs may modestly lower pulse pressure, while in some cases a drug that lowers overall blood pressure may actually have the counterproductive side effect of raising pulse pressure. Pulse pressure can both widen or narrow in people with
sepsis depending on the degree of
hemodynamic compromise. A pulse pressure of over 70 mmHg in sepsis is correlated with an increased chance of survival and a more positive response to
IV fluids.
Mean arterial pressure Mean arterial pressure (MAP) is the average of blood pressure over a
cardiac cycle and is determined by the
cardiac output (CO),
systemic vascular resistance (SVR), and
central venous pressure (CVP): :::::::::::\! \text{MAP} = (\text{CO} \cdot \text{SVR}) + \text{CVP} In practice, the contribution of CVP (which is small) is generally ignored and so :::::::::::\! \text{MAP} = \text{CO} \cdot \text{SVR} MAP is often estimated from measurements of the systolic pressure, \! P_{\text{sys}} and the diastolic pressure, \! P_{\text{dias}} This estimation is only accurate when the heart rate is around 60 peats per minute.
Regulation of blood pressure The
endogenous,
homeostatic regulation of arterial pressure is not completely understood, but the following mechanisms of regulating arterial pressure have been well-characterized: •
Baroreceptor reflex:
Baroreceptors in the
high pressure receptor zones detect changes in arterial pressure. These baroreceptors send signals ultimately to the
medulla of the brain stem, specifically to the
rostral ventrolateral medulla (RVLM). The medulla, by way of the
autonomic nervous system, adjusts the mean arterial pressure by altering both the force and speed of the heart's contractions, as well as the systemic vascular resistance. The most important arterial baroreceptors are located in the left and right
carotid sinuses and in the
aortic arch. •
Renin–angiotensin system (RAS): This system is generally known for its long-term adjustment of arterial pressure. This system allows the
kidney to compensate for loss in
blood volume or drops in arterial pressure by activating an endogenous
vasoconstrictor known as
angiotensin II. •
Aldosterone release: This
steroid hormone is released from the
adrenal cortex in response to activation of the renin-angiotensin system, high serum
potassium levels, or elevated
adrenocorticotropic hormone (ACTH). Renin converts angiotensinogen to angiotensin I, which is converted by
angiotensin converting enzyme to angiotensin II. Angiotensin II then signals to the adrenal cortex to release aldosterone. Aldosterone stimulates
sodium retention and potassium excretion by the kidneys and the consequent salt and water retention increases plasma volume, and indirectly, arterial pressure. Aldosterone may also exert direct pressor effects on vascular smooth muscle and central effects on sympathetic nervous system activity. •
Baroreceptors in
low pressure receptor zones (mainly in the
venae cavae and the
pulmonary veins, and in the
atria) result in feedback by regulating the secretion of
antidiuretic hormone (ADH/vasopressin),
renin and
aldosterone. The resultant increase in
blood volume results in an increased
cardiac output by the
Frank–Starling law of the heart, in turn increasing arterial blood pressure. These different mechanisms are not necessarily independent of each other, as indicated by the link between the RAS and aldosterone release. When blood pressure falls many physiological cascades commence in order to return the blood pressure to a more appropriate level. • The blood pressure fall is detected by a decrease in blood flow and thus a decrease in
glomerular filtration rate (GFR). • Decrease in GFR is sensed as a decrease in Na+ levels by the
macula densa. • The macula densa causes an increase in Na+ reabsorption, which causes water to follow in via
osmosis and leads to an ultimate increase in
plasma volume. Further, the macula densa releases adenosine which causes constriction of the afferent arterioles. • At the same time, the
juxtaglomerular cells sense the decrease in blood pressure and release
renin. • Renin converts
angiotensinogen (inactive form) to
angiotensin I (active form). • Angiotensin I flows in the bloodstream until it reaches the capillaries of the lungs where
angiotensin-converting enzyme (ACE) acts on it to convert it into
angiotensin II. • Angiotensin II is a vasoconstrictor that will increase blood flow to the heart and subsequently the preload, ultimately increasing the
cardiac output. • Angiotensin II also causes an increase in the release of
aldosterone from the
adrenal glands. • Aldosterone further increases the Na+ and H2O reabsorption in the
distal convoluted tubule of the
nephron. The RAS is targeted pharmacologically by
ACE inhibitors and
angiotensin II receptor antagonists (also known as angiotensin receptor blockers; ARB). The aldosterone system is directly targeted by
aldosterone antagonists. The fluid retention may be targeted by
diuretics; the antihypertensive effect of diuretics is due to its effect on blood volume. Generally, the baroreceptor reflex is not targeted in
hypertension because if blocked, individuals may experience
orthostatic hypotension and
fainting. ==Measurement==